StreetInsider.com News Articles

Form 8-K Liminatus Pharma, Inc. For: Aug 18

Tue, 18 Aug 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260818/26944224.html

Form 8-K Liminatus Pharma, Inc. For: Aug 18

Tue, 18 Aug 2026 16:06:00 -0400

si-local-file:///var/storage/secattach/20260818/26944224.html

Liminatus Pharma announces 1-for-50 reverse stock split

Tue, 18 Aug 2026 16:01:11 -0400

Liminatus Pharma, Inc. (Nasdaq: LIMN) announced that its board of directors has approved a 1-for-50 reverse stock split of its common stock, effective at the close of trading on August 20, 2026.

The company's common stock is expected to begin trading on a split-adjusted basis on the Nasdaq Capital Market under the existing ticker symbol "LIMN" at the market open on August 21, 2026. The new CUSIP number for the common stock will be 53271X 207.

Stockholders approved the reverse stock split at the company's 2026 Annual Meeting of Stockholders held on August 3, 2026.

Under the terms of the split, every 50

Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock

Tue, 18 Aug 2026 16:01:00 -0400

FULLERTON, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”) today announced that its board of directors has adopted resolutions approving a reverse stock split of its common stock, par value $0.0001 per share (“Common Stock”), at a ratio of 1-for-50 (the “Reverse Stock Split”), which was approved by stockholders at the Company’s 2026 Annual Meeting of Stockholders held on August 3, 2026. The Reverse Stock Split will take effect at the close of trading on August 20, 2026, and the Company’s Common Stock is expected to begin trading on

Liminatus Pharma, Inc. Announces Reverse Stock Split of its Common Stock

Tue, 18 Aug 2026 16:01:00 -0400

Form 10-Q Liminatus Pharma, Inc. For: Jun 30

Fri, 14 Aug 2026 16:51:00 -0400

si-local-file:///var/storage/secattach/20260814/26932233.html

Form 10-Q Liminatus Pharma, Inc. For: Jun 30

Fri, 14 Aug 2026 16:51:00 -0400

si-local-file:///var/storage/secattach/20260814/26932233.html

Liminatus Pharma moves to Nasdaq Capital Market amid bid price issue

Thu, 13 Aug 2026 07:15:07 -0400

Liminatus Pharma, Inc. (NASDAQ: LIMN) announced that its common stock was transferred from the Nasdaq Global Market to the Nasdaq Capital Market, effective August 4, 2026, according to a company press release.

The Nasdaq Hearings Panel has granted the biopharmaceutical company an extension to demonstrate compliance with Nasdaq's minimum bid price requirement, giving the company until September 3, 2026 to meet the standard.

The company's shares will continue trading under the ticker symbol "LIMN" during the extension period, subject to compliance with the panel's decision and other applicable Nasdaq continued listing requirements.

"We are pleased to have completed the transfer to the Nasdaq

Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement

Thu, 13 Aug 2026 07:15:00 -0400

FULLERTON, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”), a biopharmaceutical company developing novel therapies for cancer and other serious diseases, today announced that its common stock was transferred from the Nasdaq Global Market to the Nasdaq Capital Market, effective August 4, 2026, and that the Nasdaq Hearings Panel (the “Panel”) has granted the Company additional time to demonstrate compliance with Nasdaq’s minimum bid price requirement.

The transfer to the Nasdaq Capital Market allows the Company’s common stock to continue trading on Nasdaq under its existing ticker symbol, “LIMN.” The

Liminatus Pharma Announces Transfer to Nasdaq Capital Market and Extension to Regain Compliance with Minimum Bid Price Requirement

Thu, 13 Aug 2026 07:15:00 -0400

The transfer to the Nasdaq Capital Market allows the Company’s common stock to continue trading on Nasdaq under its existing ticker symbol, “LIMN.” The

Form 8-K Liminatus Pharma, Inc. For: Aug 03

Tue, 04 Aug 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260804/26867061.html

Form 8-K Liminatus Pharma, Inc. For: Aug 03

Tue, 04 Aug 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260804/26867061.html

Form 8-K Liminatus Pharma, Inc. For: Jul 29

Thu, 30 Jul 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260730/26837893.html

Form 8-K Liminatus Pharma, Inc. For: Jul 29

Thu, 30 Jul 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260730/26837893.html

Form 8-K Liminatus Pharma, Inc. For: Jul 20

Fri, 24 Jul 2026 16:51:00 -0400

si-local-file:///var/storage/secattach/20260724/26814127.html

Form 8-K Liminatus Pharma, Inc. For: Jul 20

Fri, 24 Jul 2026 16:51:00 -0400

si-local-file:///var/storage/secattach/20260724/26814127.html

Form SCHEDULE 13G Liminatus Pharma, Inc. Filed by: Samda Biolab Co., Ltd.

Wed, 22 Jul 2026 17:08:00 -0400

si-local-file:///var/storage/secattach/20260722/26802598.html

Form SCHEDULE 13G Liminatus Pharma, Inc. Filed by: Samda Biolab Co., Ltd.

Wed, 22 Jul 2026 17:08:00 -0400

si-local-file:///var/storage/secattach/20260722/26802598.html

Form 4 Liminatus Pharma, Inc. For: Jul 02 Filed by: Kim Chris

Tue, 14 Jul 2026 17:46:00 -0400

si-local-file:///var/storage/secattach/20260714/26769228.html

Form 4 Liminatus Pharma, Inc. For: Jul 02 Filed by: Kim Chris

Tue, 14 Jul 2026 17:46:00 -0400

si-local-file:///var/storage/secattach/20260714/26769228.html

Form SCHEDULE 13D/A Liminatus Pharma, Inc. Filed by: Valetudo Therapeutics LLC

Tue, 14 Jul 2026 17:36:00 -0400

si-local-file:///var/storage/secattach/20260714/26769208.html

Form SCHEDULE 13D/A Liminatus Pharma, Inc. Filed by: Valetudo Therapeutics LLC

Tue, 14 Jul 2026 17:36:00 -0400

si-local-file:///var/storage/secattach/20260714/26769208.html

Form DEF 14A Liminatus Pharma, Inc. For: Aug 03

Mon, 13 Jul 2026 08:44:00 -0400

si-local-file:///var/storage/secattach/20260713/26760393.html

Form DEF 14A Liminatus Pharma, Inc. For: Aug 03

Mon, 13 Jul 2026 08:44:00 -0400

si-local-file:///var/storage/secattach/20260713/26760393.html

Form 4 Liminatus Pharma, Inc. For: Jun 24 Filed by: Kim Chris

Mon, 06 Jul 2026 16:59:00 -0400

si-local-file:///var/storage/secattach/20260706/26736390.html